News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Research>Nomura: NetEase (NTES.US) 1Q Results Beat, Game Biz Continues to Recover
NTES-S (09999.HK)(NTES.US)'s 1Q25 results were strong, with both revenue and profit margin beating expectations, according to Nomura's research report. During the period, t...
Reset
Send
The window will close in 5 seconds
<Research>Nomura: NetEase (NTES.US) 1Q Results Beat, Game Biz Continues to Recover
Close
Recommend
2
Positive
3
Negative
3
 
 

NTES-S (09999.HK)  +21.900 (+13.028%)    Short selling $496.88M; Ratio 12.594%   (NTES.US)      's 1Q25 results were strong, with both revenue and profit margin beating expectations, according to Nomura's research report.

During the period, the game business continued to recover, with online game revenue growing by 15% YoY, significantly accelerating from the 5% growth in 4Q24, higher than the market consensus of a 10% incline. This was mainly driven by the continued strong sales of its flagship games like 'Identity V', the launch of new games like 'Marvel Rivals' and 'When Winds Meet' and the contribution from the return of Blizzard's games.

Related NewsNTES-S 1Q NP Up 35% YoY to RMB10.3B Largely Beats Forecast
Therefore, Nomura rated NTES-S' US stock at Buy, with a target price of US$124.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-05-16 16:25.) (Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

AASTOCKS Financial News
Website: www.aastocks.com

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.